Literature DB >> 7306576

Pinocytic uptake and intracellular degradation of N-(2-hydroxypropyl)methacrylamide copolymers. A potential drug delivery system.

R Duncan, P Rejmanova, J Kopecek, J B Lloyd.   

Abstract

Synthetic 125I-labelled N-(2-hydroxypropyl)methacrylamide copolymers containing four different, potentially degradable peptidyl side chains were incubated with rat visceral yolk sacs cultured in vitro. All copolymers were captured by fluid-phase pinocytosis and three of the side chains were susceptible to lysosomal hydrolysis, resulting in release of [125I]iodotyrosine back into the culture medium. Uptake and degradation was completely inhibited by 2,4-dinitrophenol. The thiol-proteinase inhibitor leupeptin did not affect the rate of pinocytosis, but caused different degrees of inhibition of hydrolysis depending on side chain composition.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 7306576     DOI: 10.1016/0304-4165(81)90058-1

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  12 in total

Review 1.  Polymer-drug conjugates: recent development in clinical oncology.

Authors:  Chun Li; Sidney Wallace
Journal:  Adv Drug Deliv Rev       Date:  2008-02-08       Impact factor: 15.470

Review 2.  Beyond oncology--application of HPMA copolymers in non-cancerous diseases.

Authors:  Xin-Ming Liu; Scott C Miller; Dong Wang
Journal:  Adv Drug Deliv Rev       Date:  2009-11-10       Impact factor: 15.470

3.  Immunogenicity of N-(2-hydroxypropyl)-methacrylamide copolymers--potential hapten or drug carriers.

Authors:  B Ríhová; K Ulbrich; J Kopecek; P Mancal
Journal:  Folia Microbiol (Praha)       Date:  1983       Impact factor: 2.099

4.  Enhanced antitumor activity of combinations of free and HPMA copolymer-bound drugs.

Authors:  J Hongrapipat; P Kopecková; S Prakongpan; J Kopecek
Journal:  Int J Pharm       Date:  2007-09-22       Impact factor: 5.875

Review 5.  Macromolecular therapeutics.

Authors:  Jiyuan Yang; Jindřich Kopeček
Journal:  J Control Release       Date:  2014-04-18       Impact factor: 9.776

6.  Endocytic uptake of a large array of HPMA copolymers: Elucidation into the dependence on the physicochemical characteristics.

Authors:  Jihua Liu; Hillevi Bauer; Jon Callahan; Pavla Kopecková; Huaizhong Pan; Jindrich Kopecek
Journal:  J Control Release       Date:  2010-01-04       Impact factor: 9.776

Review 7.  Macromolecular therapeutics: advantages and prospects with special emphasis on solid tumour targeting.

Authors:  Khaled Greish; Jun Fang; Takao Inutsuka; Akinori Nagamitsu; Hiroshi Maeda
Journal:  Clin Pharmacokinet       Date:  2003       Impact factor: 6.447

8.  N-(2-hydroxypropyl)methacrylamide copolymers targeted to the hepatocyte galactose-receptor: pharmacokinetics in DBA2 mice.

Authors:  L W Seymour; K Ulbrich; S R Wedge; I C Hume; J Strohalm; R Duncan
Journal:  Br J Cancer       Date:  1991-06       Impact factor: 7.640

9.  Comparison of the liver subcellular distribution of free daunomycin and that bound to galactosamine targeted N-(2-hydroxypropyl)methacrylamide copolymers, following intravenous administration in the rat.

Authors:  S R Wedge; R Duncan; P Kopeckova
Journal:  Br J Cancer       Date:  1991-04       Impact factor: 7.640

10.  Combination chemotherapy and photodynamic therapy with fab' fragment targeted HPMA copolymer conjugates in human ovarian carcinoma cells.

Authors:  Jarunee Hongrapipat; Pavla Kopecková; Jihua Liu; Sompol Prakongpan; Jindrich Kopecek
Journal:  Mol Pharm       Date:  2008-08-27       Impact factor: 4.939

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.